Hebei Changshan Biochemical Pharmaceutical financials at a glance

+ Portfolio

The revenue of Hebei Changshan Biochemical Pharmaceutical is reported as 1.42016 billion Yuan Renminbi in the fiscal year 2017. The earnings were 0.2 Yuan Renminbi per share in 2017, which was 5.26 higher than 2016. And about 0.00398 billion Yuan Renminbi are reported as free cash flow in the financials of Hebei Changshan Biochemical Pharmaceutical 2017. Dividends of 0.02 Yuan Renminbi per share were paid to shareholders of Hebei Changshan Biochemical Pharmaceutical stock SZSE:300255 in fiscal 2017.

Forecast

Financials

Year	Year	TTM	2017	2016	2015	2014	2013	2012	2011
Rev.	Revenue	N/A	¥1.42B	¥1.12B	¥915.99M	¥811.28M	¥704.54M	¥575.56M	¥423.48M
GM %	Gross Margin %	29.03%	65.49%	64.69%	66.80%	58.68%	55.98%	49.32%	33.37%
OM	Operating Margin	-16.23%	18.42%	20.18%	22.22%	21.37%	20.67%	18.95%	21.46%
EPS	Earnings Per Share	¥-0.52	¥0.20	¥0.19	¥0.17	¥0.15	¥0.13	¥0.11	¥0.10
Div.	Dividends	N/A	¥0.02	¥0.02	¥0.03	¥0.02	¥0.00	¥0.00	¥0.00
PR %	Payout Ratio %	0	10.00%	10.53%	17.65%	13.33%	0	0	0
Sha.	Shares	N/AM	934.97M	934.97M	847.88M	847.88M	847.88M	847.88M	825.05M
OCF	Operating Cash Flow	N/A	¥162.28M	¥171.96M	¥-38.14M	¥-84.97M	¥-15.24M	¥-70.62M	¥17.04M
FCF	Free Cash Flow	N/A	¥3.98M	¥75.44M	¥-,123.48M	¥-,236.18M	¥-,282.44M	¥-,195.99M	¥-13.39M
FCFS	Free Cash Flow Per Share	¥-0.29	¥0.00	¥0.09	¥-0.14	¥-0.27	¥-0.33	¥-0.24	¥-0.02

Hebei Changshan Biochemical Pharmaceutical financials at a glance

Financials

Discover